109 related articles for article (PubMed ID: 23137024)
1. Genetic and protein markers related to laryngeal epithelial precursor lesions and their neoplastic progression.
Álvarez-Marcos C; López F; Alonso-Guervós M; Domínguez F; Suárez C; Hermsen MA; Llorente JL
Acta Otolaryngol; 2013 Mar; 133(3):281-90. PubMed ID: 23137024
[TBL] [Abstract][Full Text] [Related]
2. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
3. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
4. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
5. Protein expression of the tumor suppressors p16INK4A and p53 and disease progression in recurrent respiratory papillomatosis.
Pham TT; Ongkeko WM; An Y; Yi ES
Laryngoscope; 2007 Feb; 117(2):253-7. PubMed ID: 17277618
[TBL] [Abstract][Full Text] [Related]
6. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic significance and prognostic role of cyclin E and cyclin A expression in laryngeal epithelial lesions.
Fraczek M; Wozniak Z; Ramsey D; Zatonski T; Krecicki T
Acta Otolaryngol; 2008 Mar; 128(3):329-34. PubMed ID: 17917837
[TBL] [Abstract][Full Text] [Related]
8. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes.
Skálová A; Vanecek T; Majewska H; Laco J; Grossmann P; Simpson RH; Hauer L; Andrle P; Hosticka L; Branžovský J; Michal M
Am J Surg Pathol; 2014 Jan; 38(1):23-33. PubMed ID: 24145651
[TBL] [Abstract][Full Text] [Related]
9. Molecular biology of laryngeal squamous cell carcinoma.
Nadal A; Cardesa A
Virchows Arch; 2003 Jan; 442(1):1-7. PubMed ID: 12536308
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins.
Iwasa A; Oda Y; Kurihara S; Ohishi Y; Yasunaga M; Nishimura I; Takagi E; Kobayashi H; Wake N; Tsuneyoshi M
Pathol Int; 2008 Dec; 58(12):757-64. PubMed ID: 19067849
[TBL] [Abstract][Full Text] [Related]
11. Alterations of p53 and Bcl-2 protein expression in the recurrent laryngeal and pharyngeal squamous cell carcinoma.
Rashad UM; Hussein MR; Algizawy SM
Am J Otolaryngol; 2011; 32(3):210-4. PubMed ID: 20434805
[TBL] [Abstract][Full Text] [Related]
12. Regulators of proliferation and apoptosis in carcinoma of the larynx.
Whisler LC; Wood NB; Caldarelli DD; Hutchinson JC; Panje WR; Friedman M; Preisler HD; Leurgans S; Nowak J; Coon JS
Laryngoscope; 1998 May; 108(5):630-8. PubMed ID: 9591537
[TBL] [Abstract][Full Text] [Related]
13. Morphometric analysis of Ki-67 and p16 expression in laryngeal precursor lesions.
Pavlovic B; Djukic V; Milovanovic J; Tomanovic N; Milovanovic A; Trivic A
Eur Arch Otorhinolaryngol; 2013 Mar; 270(4):1405-10. PubMed ID: 23408022
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
15. From laryngeal epithelial precursor lesions to squamous carcinoma of the larynx: the role of cell cycle proteins and β-catenin.
López F; Alvarez-Marcos C; Alonso-Guervós M; Domínguez F; Suárez C; Hermsen MA; Llorente JL
Eur Arch Otorhinolaryngol; 2013 Nov; 270(12):3153-62. PubMed ID: 23564160
[TBL] [Abstract][Full Text] [Related]
16. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.
Li YR; Wu JM; Wang L; Huang X; Shi J; Hu LH
Acta Otolaryngol; 2005 Apr; 125(4):409-14. PubMed ID: 15823813
[TBL] [Abstract][Full Text] [Related]
17. [Relative factors analysis including carcinoma marker, molecular margin and clinical factors on laryngeal carcinoma recurrence].
Yi H; Zhang B; Liu P; Ni F; Li Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Jun; 22(12):529-31. PubMed ID: 18800676
[TBL] [Abstract][Full Text] [Related]
18. Molecular and immunohistochemical analysis of the bcl-1/cyclin D1 gene in laryngeal squamous cell carcinomas: correlation of protein expression with lymph node metastases and advanced clinical stage.
Fracchiolla NS; Pruneri G; Pignataro L; Carboni N; Capaccio P; Boletini A; Buffa R; Neri A
Cancer; 1997 Mar; 79(6):1114-21. PubMed ID: 9070488
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 protein tissue detection in laryngeal cancer.
Segas JV; Lazaris AC; Nikolopoulos TP; Kavantzas NG; Lendari IE; Tzagkaroulakis AM; Patsouris ES; Ferekidis EA
ORL J Otorhinolaryngol Relat Spec; 2005; 67(6):319-25. PubMed ID: 16327270
[TBL] [Abstract][Full Text] [Related]
20. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
